First of all, the company introduced to readers is Li Sheng Pharmaceutical, which and its holding subsidiaries are mainly engaged in the production and sales of chemical tablets, hard capsules, dripping pills, freeze-dried powder injections, water injections, raw materials and other products. After years of efforts, Li Sheng Pharmaceutical has established a good product reputation and corporate image in the market, and its flagship product brand "Longevity is better than goodness" has long been deeply rooted in people's hearts.
Secondly, Huahai Pharmaceutical Co., Ltd. is the first listed pharmaceutical company in China whose preparations have passed FDA certification, achieved large-scale export and challenged the original research patents in the United States. With the vertical integration advantages of raw materials and preparations, Huahai Pharmaceutical Co., Ltd. has occupied a major share of the raw material drug market. As for raw materials, the company is also a leading domestic raw material enterprise, and is also in a leading position in the international raw material market. Its customers cover more than 65,438+000 countries around the world, especially in the field of cardiovascular drugs, and it is one of the major suppliers of pulverization and sartan drugs in the world.
The last company I introduced to you was Hengrui Pharma. The company built a series of R&D platforms, and took the lead in applying for the internationally leading antibody toxin combined with ADC drugs in China. Up to now, the company's innovative drugs, such as aricoxib, Apatinib Mesylate, Pioglitazone, Pyritinib Maleate, Karezumab, Rimazzolam Toluene Sulfonate, and Fluzopali, have all been listed. At present, nearly 20 projects have been approved to carry out global multi-center or regional clinical research. Among them, carelizumab, Apatinib, Fluzopali and other key products have carried out phase III clinical trials in international multi-centers.
What I have shared with you above are several pharmaceutical companies with great strength in the A-share market. In the future, with the development and progress of related industries, there will be more opportunities waiting for them. I hope this article can bring beneficial help and inspiration to your investment!